Related Experiment Videos
Current treatment and future prospects for the management of acute coronary syndromes
1Department of Clinical Pharmacology, University of Zimbabwe Medical School, Harare, Zimbabwe. kbhagat@healthnet.zw
Insights
Ischaemic heart disease burdens cardiovascular disease globally, especially in developing nations. Management focuses on retarding thrombosis and modifying vasoconstriction to improve outcomes.
Area of Science:
- Cardiology
- Vascular Biology
- Public Health
Background:
- Ischaemic heart disease (IHD) significantly contributes to the global cardiovascular disease (CVD) burden.
- While IHD incidence may be stabilizing in Western countries, its impact is emerging in less industrialized regions.
- Advances in diagnosing and managing acute coronary syndromes (ACS) are crucial.
Purpose of the Study:
- To review critical therapeutic strategies for managing ischaemic heart disease.
- To highlight interventions targeting haemostatic balance and vasoconstriction.
Main Methods:
- Review of therapeutic strategies for ischaemic heart disease.
- Focus on interventions impacting haemostasis and vasoconstriction.
Main Results:
- Therapeutic strategies involve two key areas: modulating the haemostatic balance to inhibit thrombosis.
- Interventions also focus on modifying local and systemic vasoconstricting stimuli.
Conclusions:
- Effective management of ischaemic heart disease requires addressing both thrombotic processes and vasoconstriction.
- These strategies are critical for mitigating the escalating global burden of cardiovascular disease.
Abstract:
The impact of ischaemic heart disease on the burden of cardiovascular disease continues to escalate worldwide, although international statistics suggest a levelling off in Western world, in the less industrialised parts of the world the effects of this disease are only beginning to be documented, nonetheless, rapid advances have been made in the diagnosis and management of the acute coronary syndromes (the term which encompasses the protean clinical manifestations of the ischaemic process). The therapeutic strategies discussed in this article cover two broad subjects that have been found to be critical in the evolution of the disease:- i. interfering with the haemostatic balance by retarding the thrombotic process; ii. modifying local and systemic vasoconstricting stimuli.